Los Angeles Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
199,047
+140,150
| +238% | +$1.13M | 0.01% | 499 |
|
|
2025
Q1 | $494K | Buy |
+58,897
| New | +$494K | ﹤0.01% | 746 |
|
|
2023
Q4 | – | Sell |
-209,580
| Closed | -$884K | – | 1128 |
|
|
2023
Q3 | $884K | Buy |
209,580
+39,940
| +24% | +$169K | ﹤0.01% | 680 |
|
|
2023
Q2 | $526K | Sell |
169,640
-16,156
| -9% | -$50.1K | ﹤0.01% | 841 |
|
|
2023
Q1 | $258K | Sell |
185,796
-7,049
| -4% | -$9.8K | ﹤0.01% | 1060 |
|
|
2022
Q4 | $384K | Sell |
192,845
-10,150
| -5% | -$20.2K | ﹤0.01% | 962 |
|
|
2022
Q3 | $410K | Sell |
202,995
-1,340
| -0.7% | -$2.71K | ﹤0.01% | 979 |
|
|
2022
Q2 | $650K | Buy |
204,335
+28,604
| +16% | +$91K | ﹤0.01% | 866 |
|
|
2022
Q1 | $733K | Sell |
175,731
-1,900
| -1% | -$7.93K | ﹤0.01% | 885 |
|
|
2021
Q4 | $851K | Sell |
177,631
-3,279
| -2% | -$15.7K | ﹤0.01% | 778 |
|
|
2021
Q3 | $966K | Buy |
180,910
+6,490
| +4% | +$34.7K | ﹤0.01% | 776 |
|
|
2021
Q2 | $893K | Buy |
174,420
+115,870
| +198% | +$593K | ﹤0.01% | 906 |
|
|
2021
Q1 | $394K | Buy |
58,550
+34,515
| +144% | +$232K | ﹤0.01% | 1320 |
|
|
2020
Q4 | $110K | Hold |
24,035
| – | – | ﹤0.01% | 1495 |
|
|
2020
Q3 | $93K | Hold |
24,035
| – | – | ﹤0.01% | 1422 |
|
|
2020
Q2 | $114K | Sell |
24,035
-7,565
| -24% | -$35.9K | ﹤0.01% | 1427 |
|
|
2020
Q1 | $110K | Buy |
+31,600
| New | +$110K | ﹤0.01% | 1287 |
|